AAAAAA
Results:
1-13
|
Results: 13
Authors:
Eisen, HJ
Hobbs, RE
Davis, SF
Carrier, M
Mancini, DM
Smith, A
Valantine, I
Ventura, H
Mehra, M
Vachiery, JL
Rayburn, BK
Canver, CC
Laufer, G
Costanzo, MR
Copeland, J
Dureau, G
Frazier, OH
Dorent, R
Hauptman, PJ
Kells, C
Masters, R
Michaud, JL
Paradis, I
Renlund, DG
Vanhaecke, J
Mellein, B
Mueller, EA
Citation: Hj. Eisen et al., Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: A randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine: Results at 24 months after transplantation, TRANSPLANT, 71(1), 2001, pp. 70-78
Authors:
Holvoet, P
Van de Werf, F
Vanhaecke, J
Collen, D
Citation: P. Holvoet et al., Oxidized low-density lipoprotein and malondialdehyde-modified low-density lipoprotein: Markers of coronary artery disease, AM HEART MG, 2001, pp. 159-171
Authors:
Holvoet, P
Van Cleemput, J
Collen, D
Vanhaecke, J
Citation: P. Holvoet et al., Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease, ART THROM V, 20(3), 2000, pp. 698-702
Authors:
Pardaens, K
Van Cleemput, J
Vanhaecke, J
Fagard, RH
Citation: K. Pardaens et al., Peak oxygen uptake better predicts outcome than submaximal respiratory data in heart transplant candidates, CIRCULATION, 101(10), 2000, pp. 1152-1157
Authors:
Verleden, GM
Buyse, B
Delcroix, M
Fabri, R
Vanhaecke, J
Van Raemdonck, D
Lerut, T
Demedts, M
Citation: Gm. Verleden et al., Cyclophosphamide rescue therapy for chronic rejection after lung transplantation, J HEART LUN, 18(11), 1999, pp. 1139-1142
Authors:
Vanhaecke, J
Van Cleemput, J
Droogne, W
Fagard, R
Staessen, J
Citation: J. Vanhaecke et al., Out-patient versus in-hospital ambulatory 24-h blood pressure monitoring in heart transplant recipients, J HUM HYPER, 13(3), 1999, pp. 199-202
Authors:
Shivalkar, B
Flameng, W
Szilard, M
Pislaru, S
Borgers, M
Vanhaecke, J
Citation: B. Shivalkar et al., Repeated stunning precedes myocardial hibernation in progressive multiple coronary artery obstruction, J AM COL C, 34(7), 1999, pp. 2126-2136
Authors:
Matejovicova, M
Shivalkar, B
Vanhaecke, J
Szilard, M
Flameng, W
Citation: M. Matejovicova et al., Protein kinase C expression and subcellular distribution in chronic myocardial ischemia. Comparison of two different canine models, MOL C BIOCH, 201(1-2), 1999, pp. 73-82
Authors:
Fagard, R
Pardaens, K
Vanhaecke, J
Citation: R. Fagard et al., Prognostic significance of exercise versus resting blood pressure in patients with chronic heart failure, J HYPERTENS, 17(12), 1999, pp. 1977-1981
Authors:
De Geest, S
Vanhaecke, J
Citation: S. De Geest et J. Vanhaecke, Methodological issues in transplant compliance research, TRANSPLAN P, 31(4A), 1999, pp. 81S-83S
Authors:
Eisen, HJ
Hobbs, RE
Davis, SF
Laufer, G
Mancini, DM
Renlund, DG
Valantine, H
Ventura, H
Vachiery, JL
Bourge, RC
Canver, CC
Carrier, M
Costanzo, MR
Copeland, J
Dureau, G
Frazier, OH
Dorent, R
Hauptman, PJ
Kells, C
Masters, R
Michaud, JL
Paradis, I
Smith, A
Vanhaecke, J
Feutren, G
Turkin, D
Mellein, B
Mueller, EA
Citation: Hj. Eisen et al., Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: A randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine - Results at six months after transplantation, TRANSPLANT, 68(5), 1999, pp. 663-671
Authors:
Pardaens, K
Van Cleemput, J
Vanhaecke, J
Fagard, RH
Citation: K. Pardaens et al., Prediction of peak exercise oxygen uptake by cardiopulmonary measurements at rest in heart transplant candidates, ACT CARDIOL, 54(6), 1999, pp. 345-354
Authors:
Bresseleers, D
Flameng, W
Vanhaecke, J
Citation: D. Bresseleers et al., Anomalous origin of a coronary artery in a transplanted heart, ACT CARDIOL, 54(2), 1999, pp. 93-96
Risultati:
1-13
|